 |
First-Line Therapy For Schizophrenia Clears Committee
Pfizer Inc. said today that an Advisory
Committee to the U.S. Food and Drug Administration (FDA) recommended approval of Zeldox® (ziprasidone HCl) for the treatment of schizophrenia.
Discovered and developed by Pfizer, Zeldox® is a serotonin and dopamine
antagonist that is effective in treating the wide range of positive, negative
and depressive symptoms associated with schizophrenia.
More...
|
|
 |
Vaccine Recommendations For The 2000--01 Influenza Season
For the 2000--01 influenza season in the United States, lower than anticipated production yields for this year's influenza A(h5N2) vaccine component and
manufacturing problems are expected to lead to a substantial delay in the
distribution of influenza vaccine. Because many
vaccine providers currently are planning their fall vaccination activities, CDC and the Advisory Committee on Immunization Practices (ACIP) are issuing adjunct influenza vaccination recommendations beyond those made by ACIP on April 14, 2000.
More...
|
|
 |
A Comprehensive Look At Schizophrenia
Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1 percent of the population develops schizophrenia during their lifetime more than 2 million Americans suffer from the illness in a given year. Although schizophrenia affects men and women with equal frequency, the disorder often appears earlier in men, usually in the late teens or early twenties, than in women, who are generally affected in the twenties to early thirties. More...
|
|
 |
Acupuncture - Information & Resources
Acupuncture is one of the oldest, most commonly
used medical procedures in the world. Originating in China more than 2,000
years ago, acupuncture became widely known in the United States in 1971
when New York Times reporter James Reston wrote about how doctors
in Beijing, China, used needles to ease his abdominal pain after surgery.
Research shows that acupuncture is beneficial in treating a variety of
health conditions.
More... |
|